Archbow Consulting opened for business one year ago this month. We formed the company because we thought we could apply our diverse real-world experience and deep industry connections in a way that would truly help pharma companies better meet their commercialization needs.
We’re been humbled to see that vision brought to life.
From day one, our clients and the biopharmaceutical industry at large embraced us in a way that let us know we were on the right track. Our first year exceeded our expectations. For that, we’re endlessly grateful for the people who trusted us with their business and those who helped us meet the demand.
Over the course of our fist year, we helped companies bring all types of therapies – from traditional specialty to ultra-orphan to cutting edge gene therapies – to market. We aided others by optimizing existing programs to better compete in today’s marketplace. Our work this year alone led us to collaborate with a wide-assortment of organizations in locations ranging from Australia to Singapore to Kansas.
We also had a lot of fun along the way.
The Archbow team donned red noses as part of national Red Nose Day.
Kea Lingo, Greenwich Biosciences, Lauren Cole, Archbow Consulting, DeWayne Manning, Archbow Consulting, and Barrett Land, Greenwich Biosciences, at the Epilepsy Foundation of Greater Los Angeles’s Care + Cure Gala.
Douglas Bock and Kevin Cast went back to school at the University of Oxford to study Blockchain Technology.
A deep, heart-felt thank you goes out to our clients and employees – you’re the reason we’re celebrating these milestones. We look forward to working with you for years to come.